Review of Iranian instruction programs for clinical pharmacy

Zahra Tolou-Ghamari

Abstract


It is well known that clinical pharmacists could play an important role associated to pharmacotherapy management for each disorder. Therefore, keeping an applied evidence-based-strategy should be considered as instructed program based on awareness toward profession. This study aimed to describe all challenges regarding to clinical pharmacy teaching programs' that Iranian faculty of pharmacy might face with it. In order to attain high excellence, evidence based pharmacotherapy care should be considered as rational developing insight linked to the clinical pharmacy instruction program. Individual experience or expert judgment alone seem to be not sufficient to support final decision for each patient, therefore there is need for inserting packages that included pharmacotherapy strategy associated to monitoring and assessing clinical response. Finally, establishing evidence-based practice is important for pharmacotherapy care in order to be effective, rationalized and applicable to patients' population. For performing a suitable teaching model toward clinical pharmacy courses, Iranian clinical pharmacist tutors must accept and vigorously contribute in the investigation desired to launch the required evidence-base pharmacotherapy care that accompanied by undergraduate and postgraduate pharmacy students.


Keywords


Teaching, Pharmacy, Clinical, Hospital, Pharmacotherapy, Iranian

Full Text:

PDF

References


Nunes-da-Cunha I, Arguello B, Martinez FM, Fernandez-Llimos F. A comparison of patient-centered care in pharmacy curricula in the United States and Europe. Am J Pharm Educ 80:83, 2016.

Schneider AT, Albers P, Müller-Mattheis V. E-Learning in Urology: Implementation of the Learning and teaching platform CASUS® - Do virtual patients Llead to improved learning outcomes? A randomized study among students. Urol Int 94:412-418, 2015.

Tolou-Ghamari Z. Investigation of final causes of death in 5360 deceased patients within a teaching hospital in Isfahan, Iran. Am J Exp Clin Res 3:161-164, 2016.

Tolou-Ghamari Z. Antiepileptic drugs (AEDs) polypharmacy could lead to buried pharmacokinetic interactions due to CYP450. Drug Metab Lett 6:207-12, 2012.

Tolou-Ghamari Z, Zare M, Habibabadi JM, Najafi MR. Antiepileptic drugs: a consideration of clinical and biochemical outcome in patients with epilepsy. Int J Prev Med 4:S330-337, 2013.

Bess DT, Taylor J, Schwab CA, Wang J, Carter JA. An innovative approach to pharmacy law education utilizing a Mock Board of Pharmacy Meeting. Inov Pharm 7: pii: 9, 2016.

McNeely EB. Treatment Considerations and the Role of the clinical pharmacist throughout transitions of care for patients with acute heart failure. J Pharm Pract pii: 0897190016645435, 2016.

Shaygannejad V, Tolou-Ghamari Z. What is the real fate of vitamin D in multiple sclerosis? Int J Prev Med 4:S159-S164, 2013.

Tolou-Ghamari Z. Monitoring Tacrolimus (FK506) in Liver Transplant Recipients: A Consideration of Alternative Techniques and the Influence of Clinical Status. 1999. University of London. .

Tolou-Ghamari Z, Najafi MR, Mehavari Habibabadi J, Zare M. Preliminarily analysis of carbamazepine (CBZ) C0 in patients visited Isfahan epileptic clinics. Int J Prev Med S343-346, 2013.

Tolou-Ghamari Z, Palizban A, Tredger J. Modelling tacrolimus AUC in acute and chronic liver disease immediately after transplant. Transplantationsmedizin 16. Jahrg, S. 109, 2004.

Tolou-Ghamari Z. A review of geoepidemiological differences of multiple sclerosis in Iran and other Middle East countries. Arch Neurosci 2:e22028, 2015.

Asghari GH.R, Palizban AA, Tolou-Ghamari Z, Adeli F. Contamination of cadmium, lead and mercury on Iranian herbal medicines. Pharmaceut Sci 1:1-8, 2008.

Tolou-Ghamari Z, Shaygannejad V, Khorvash F. Preliminary Investigation of Economics Issues in Hospitalized Patients with Stroke. Int J Prev Med 4:S338-S342, 2013.

Tolou-Ghamari Z. Demographic analysis of patients with multiple sclerosis: Individual variability related to the time interval. Arch Neurosci 2:e21806, 2015.

Tolou-Ghamari Z, Mortazavi M, Paliuzban AA, Najafi MR. The investigation of correlation between Iminoral concentration and neurotoxic levels after kidney transplantation. Adv Biomed Res 4:59, 2015.

Tolou_Ghamari, Palizban AA. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin. Saudi Med J 25:1499-1500, 2004.

Chitsaz A, Khourvash F, Tolou-Ghamari Z, Gholamrezaei A, Noormohamadi A. Types of dizziness and its relationship with psychological symptoms in patients with chronic dizziness. Am J Exp Clin Res 3:141-145, 2016.

Tolou-Ghamari Z. Efficacy and Toxicity of Rituximab in Multiple Sclerosis. Arch Neurosci 3:e30107, 2016.

Tolou-Ghamari Z. Preliminary Study of Differences between Prevalence of Multiple Sclerosis in Isfahan and its’ Rural Provinces. Arch Neurosci 2:e29034, 2015.

Tolou-Ghamari Z. Preliminary Evidence-Based Pharmacotherapy of Mitoxantrone for Multiple Sclerosis in an Iranian Population. Thrita 4:e28644, 2015.

Tolou-Ghamari Z. Scattering month and day of baby delivery in a retrospective survey linked to 1484

patients with multiple sclerosis. Arch Neurosci 2: e27292,

Al-Quteimat OM, Amer AM. Evidence-based pharmaceutical care: The next chapter in pharmacy practice. Saudi Pharm J 24:447-451, 2016.

Chisolm-Burns M.A., Lee J.K., Spivey C.A. US pharmacists’ effect as team members on patient care: systematic review and meta-analysis. Med Care 48:923-933, 2010.

Gheewala PA, Peterson GM, Zaidi ST, Bereznicki L, Jose MD, Castelino RL. A web-based training program to support chronic kidney disease screening by community pharmacists. Int J Clin Pharm 38:1080-1086, 2016.

Kouladjian L, Danijela Gnjidic C, Hilmer SN. Education and assessment of pharmacists on the use of the drug burden index in older adults using a continuing professional development education method. Am J Pharm Educ 80:63, 2016.

Lilley A. Assessing the benefits that community pharmacies can have on childhood asthma outcomes. Arch Dis Child 101:e2, 2016.

Taylor A, Sutherland A. Clinical supervision-what about the specialist trainess? Arch Dis Child 101:e2, 2016.

Yamaguchi H. Roles of cardiology pharmacists. Yakugaku Zasshi 136:1121-1123, 2016.

Zamami Y, Koyama T, Imai T, Takemoto A, Sagara H, Sendo T, Nakura H. Pharmaceutical education focused on pharmacotherapy in emergency medical care. Yakugaku Zasshi 136:987-991, 2016.

Love DW, Heller LE, Parker PF. The use of student evaluations in examining clinical teaching in pharmacy. Drug Intell Clin Pharm 16:759-764, 1982.

Moore RL. Continuing education for the improvement of professional intervention in patient care. Drug Intell Clin Pharm 14:415-419, 1980.

Abaurre-Labrador R, Maurandi-Guillén MD, García-Delgado P, Moullin JC, Martínez-Martínez F, García-Corpas JP. Effectiveness of a protocolized dispensing service in community pharmacy for improving patient medication knowledge. Int J Clin Pharm 38:1057-1062, 2016.


Refbacks

  • There are currently no refbacks.